Navigation Links
Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
Date:6/5/2013

WASHINGTON, June 5, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.  Non-24 is a serious, rare and chronic circadian rhythm disorder that affects a majority of totally blind individuals who lack light perception and cannot entrain (synchronize) their master body clock to the 24-hour day.  Currently there is no approved FDA treatment for Non-24.

In the SET study, tasimelteon achieved the primary endpoints of entrainment (synchronizing) of the melatonin (aMT6s) rhythm as compared to placebo and clinical response as measured by entrainment plus a score of greater than or equal to 3 on the Non-24 Clinical Response Scale (N24CRS).  Tasimelteon also demonstrated significant improvement versus placebo across a number of sleep and wake parameters including measures of total sleep time, nap duration, and timing of sleep, as well as in the Clinical Global Impression of Change (CGI-C), an overall global functioning scale.  In treated patients, daytime naps decreased by 46 minutes per day in the worst 25% of days in a cycle and nighttime sleep increased by 57 minutes per day during the worst 25% of nights in a cycle.

The RESET study demonstrated that continued treatment with 20mg of tasimelteon was required to maintain entrainment of melatonin and cortisol circadian rhythms in individuals with Non-24. Patients treated with tasimelteon
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
3. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
4. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
5. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
6. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
7. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
8. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
9. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
10. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
11. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
(Date:7/2/2015)... Pharma Major Lupin Limited today announced ... Russia subject to certain closing conditions. ... which recorded RUB 765 billion in sales, placing it as ... in 2014 (IMS Health). For over a decade, Russian pharmaceutical ... this trend, projecting Russia to be ...
(Date:7/2/2015)... July 2, 2015  Konica Minolta, Inc. (Konica Minolta) ... it has acquired Sawae Technologica Ltda., an X-ray system ... , through its Brazilian healthcare sales company, Konica ... Local Brazil market investment ... population exceeding 200 million, significant healthcare technical advancements and ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 2InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 3InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 4InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 5InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 6InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 7InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 8InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 9InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 10InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 11InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 12InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 13InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology 14Cylex(TM) Elects Richard A. Sandberg as Independent Director 2Cylex(TM) Elects Richard A. Sandberg as Independent Director 3Cylex(TM) Elects Richard A. Sandberg as Independent Director 4Cylex(TM) Elects Richard A. Sandberg as Independent Director 5Cylex(TM) Elects Richard A. Sandberg as Independent Director 6Cylex(TM) Elects Richard A. Sandberg as Independent Director 7
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of ... the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together ... seeks to decrease drug overdose – especially of heroin and opioid medication – ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will include fireworks ... Insurance is sharing some tips to promote the proper use of fireworks. , ... the emergency room daily with fireworks-related injuries in the month surrounding the Fourth of ...
(Date:7/2/2015)... ... 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was fully ... to write his first poem, and three years later he was publishing an entire book ... sharing with the world. "I have always believed that the best way to lift yourself ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... As Americans ... like the hot temps, skin cancer is on the rise. July is UV Safety ... are raising awareness about the importance of getting skin checks. Experts say most skin ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression ... compression socks designed for men. , For style that’s quick on its feet, ... routine. This is great news for men everywhere because a simple change in socks ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3
... Prenatal pet exposure, a mother,s delivery mode and race are influential ... according to a Henry Ford Hospital study. In a study ... found that babies who have indoor prenatal pet exposure have a ... between birth and age 2. IgE is linked to the development ...
... MONDAY, Aug. 8 (HealthDay News) -- Despite parents, best intentions, ... by the time a child eats, and that,s true even ... packs. A new study of preschoolers, lunches found that ... was at an unsafe temperature long before children started eating. ...
... found a potential new source for sexual problems among ... partners and the men,s closest friends. A study ... the University of Chicago and Cornell University has found ... shared by heterosexual men and their partners. They describe ...
... collaboration designed to speed the process of drug discovery, ... Health Sciences announced today that UC San Diego has ... institutions across the country as part of Pfizer,s Centers ... through the Centers for Therapeutic Innovation between Pfizer and ...
... tend to take their first cigarette soon after they wake ... developing lung and head and neck cancers than smokers who ... Cancer , a peer-reviewed journal of the American Cancer ... especially high risk of developing cancer and would benefit from ...
... (HealthDay News) -- Smoking increases the risk of developing a ... U.S. researchers reviewed data from more than 15,000 people, ... of 13 years, and found that there were 876 atrial ... abnormal heart rhythm was 1.32 times higher in former smokers ...
Cached Medicine News:Health News:Prenatal pet exposure, delivery mode, race are key factors in early allergy risk 2Health News:Are Kids Brown-Bagging Bacteria? 2Health News:Are Kids Brown-Bagging Bacteria? 3Health News:When a man's partner is too close to his friends, his sex life may suffer 2Health News:When a man's partner is too close to his friends, his sex life may suffer 3Health News:UCSD Health Sciences partners with Pfizer to speed drug delivery 2Health News:UCSD Health Sciences partners with Pfizer to speed drug delivery 3Health News:Early morning smokers have increased risk of lung and head and neck cancers 2
... temporary internal drainage from the ureteropelvic junction ... stricture. The segment with no sideports prevents ... preventing ingrowth of the ureteral wall to ... Intended for one-time use. CAUTION: Periodic evaluation ...
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... placement to stent the ureter ... continent urinary diversions. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... remain indwelling more than six ...
... Used for stone manipulation and removal in the ... basket to retain its shape following extreme torsion. ... capture by allowing the basket to open at ... stone. The tipless design reduces the likelihood of ...
Medicine Products: